Welcome to our Antimalarial Ligands section, meticulously curated for the dynamic realm of scientific services and research and development (R&D) in infectious diseases, pharmacology, and drug discovery. Explore our comprehensive collection of high-quality antimalarial ligands meticulously engineered to drive innovation and propel advancements in various industries. From small molecules targeting key enzymes and pathways in the malaria parasite to novel drug candidates and screening libraries, our selection serves as the foundation for cutting-edge projects in R&D. Whether you're studying antimalarial mechanisms, investigating drug resistance, or developing novel therapeutics for malaria, our Antimalarial Ligands offer versatility, reliability, and precision for your scientific services and R&D endeavors. Discover the potential of antimalarial ligands in your next breakthrough project.
Antimalarial ligands
- SGC-CBP30, Inhibitor of CREB binding protein;Inhibitor of E1A binding protein p300
Cas#:1613695-14-9
Starting at $98.90
- INK 128 (MLN0128), Serine/threonine-protein kinase mTOR inhibitor
Cas#:1224844-38-5
Starting at $94.90
- Panobinostat (LBH589), Inhibitor of histone deacetylase 1;Inhibitor of histone deacetylase 2;Inhibitor of histone deacetylase 3;Inhibitor of histone deacetylase 4;Inhibitor of histone deacetylase 6;Inhibitor of histone deacetylase 7;Inhibitor of histone deacetylase 8;Inhibitor
Cas#:404950-80-7
Starting at $64.90
- ML324, Inhibitor of lysine demethylase 4A;Inhibitor of lysine demethylase 4E
Cas#:1222800-79-4
Starting at $55.90